Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.55 | N/A | -0.70% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.70% |
Tone: Defensive
Overall, management expressed caution regarding the current economic conditions. They highlighted the importance of maintaining operational efficiency.
Management noted that they are facing some headwinds in the current market environment.
They emphasized their commitment to long-term growth despite short-term challenges.
Thermo Fisher Scientific reported earnings that missed expectations, leading to a 4.2% drop in stock price. The company did not provide revenue figures or future guidance, which may have contributed to investor uncertainty. Management's cautious tone suggests they are navigating challenges in the market, impacting investor sentiment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
GRACO INC
Jan 27, 2020